³ÉÈËÖ±²¥

Thursday, April 16, 2026

Tag: immunotherapy

Man and woman at a computer screen
Health & Wellness

UofL and UofL Health receive $11.5 million to develop new cancer...

Betty Coffman -
Cancer remains one of the greatest health concerns in the U.S., but University of Louisville cancer researchers and UofL Health – Brown Cancer Center...
UofL Health – Brown Cancer Center
Health & Wellness

Gibbs Foundation invests $3 million with UofL Health – Brown Cancer...

UofL Health -
The University of Louisville, UofL Health – Brown Cancer Center and the Gibbs Foundation will continue their partnership in finding a cure for cancer...
Study team members Kavitha Yaddanapudi, associate professor of surgery (center), with co-first authors Omar Sarkar, UofL graduate student, (left) and Howard Donninger, UofL assistant professor (right). UofL photo.
Advancing our Health

UofL research shows existing drug improves cancer immunotherapy effectiveness

Betty Coffman -
Cancer patients may have a better chance of recovery thanks to a discovery by a research team at the University of Louisville. In a...
UofL researchers announced $6.1 million funding to expand understanding of immune dysregulation. Left to right: Jeffrey Bumpous, Jason Smith, Sean Clifford, Jiapeng Huang, Kenneth McLeish, Jun Yan, Toni Ganzel and Kevin Gardner
Advancing our Health

Taming a frenzied immune system UofL receives $6.1 million to study...

Betty Coffman -
Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to...
Facility team in the of the UofL Health - Brown Cancer Center GMP Manufacturing Facility at the University of Louisville.
Advancing our Health

IN8bio partners with UofL’s Dunbar CAR T-Cell Program as the Manufacturing...

Betty Coffman -
IN8bio Inc., a clinical-stage biopharmaceutical company discovering and developing innovative gamma-delta T-cell therapies that utilize its DeltEx platform, has selected the UofL Health -...
Jun Yan, center, leads research to better understand immune dysregulation leading to acute respiratory distress in COVID-19 and other conditions. Yan and colleagues, including Anne Geller, right, discovered a specific type of immune cell associated with immune system overreaction in 2020 while treating COVID-19 patients. The work recently was funded by $5.8 in NIH grants.
Advancing our Health

UofL receives $11.5 million to advance cancer immunotherapies Center for Cancer...

Betty Coffman -
Cancer remains one of the most difficult and deadly challenges in human health, affecting Kentuckians at a higher rate than residents of any other...
Louisville resident Thomas E. Dunbar has pledged $1 million to the University of Louisville to create a specialized center to provide chimeric antigen receptor positive T (CAR T) cell therapies to patients at the UofL James Graham Brown Cancer Center and other centers in Kentucky and the Midwest.
Health & Wellness

UofL secures $1 million donation to bring more advanced immunotherapy treatment...

Betty Coffman -
Cancer patients in Louisville, in Kentucky and throughout the region soon will have access to some of the most advanced immunotherapy treatments available. Louisville...
A confocal microscope image shows the SA-4-1BBL (green color) bound to its receptor on an immune cell (red color) to initiate an immune activation cascade to fight cancer. Image courtesy University of Louisville.
Health & Wellness

UofL researchers discover immune stimulant molecule shown to prevent cancer

Betty Coffman -
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy also protects against future...
The Breakthrough: Immunotherapy and the Race to Cure Cancer
³ÉÈËÖ±²¥ & Leadership

New York Times bestselling author, University of Chicago researcher to discuss...

Jill Scoggins -
The University of Louisville James Graham Brown Cancer Center and School of Medicine will present a free seminar open to the public on immunotherapy...